CN102336754B - 恩替卡韦的合成方法及其中间体化合物 - Google Patents
恩替卡韦的合成方法及其中间体化合物 Download PDFInfo
- Publication number
- CN102336754B CN102336754B CN201110196709.XA CN201110196709A CN102336754B CN 102336754 B CN102336754 B CN 102336754B CN 201110196709 A CN201110196709 A CN 201110196709A CN 102336754 B CN102336754 B CN 102336754B
- Authority
- CN
- China
- Prior art keywords
- compound
- phenyl
- bume
- group
- independently selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 *[C@@](OC1)O[C@](CC2)[C@@]1C2=C Chemical compound *[C@@](OC1)O[C@](CC2)[C@@]1C2=C 0.000 description 8
- QDGZDCVAUDNJFG-FXQIFTODSA-N C=C([C@H](CO)[C@H](C1)O)[C@H]1[n]1c(N=C(N)NC2=O)c2nc1 Chemical compound C=C([C@H](CO)[C@H](C1)O)[C@H]1[n]1c(N=C(N)NC2=O)c2nc1 QDGZDCVAUDNJFG-FXQIFTODSA-N 0.000 description 2
- KBRBOCUHDVZKGJ-YUMQZZPRSA-N C=C(CC1)[C@H]2[C@H]1OCOC2 Chemical compound C=C(CC1)[C@H]2[C@H]1OCOC2 KBRBOCUHDVZKGJ-YUMQZZPRSA-N 0.000 description 1
- NJJREMPNVDBNBA-STQMWFEESA-N CC(C)(C)[Si+](C(C)(C)C)(OC1)O[C@@H](CC2)[C@@H]1C2=C Chemical compound CC(C)(C)[Si+](C(C)(C)C)(OC1)O[C@@H](CC2)[C@@H]1C2=C NJJREMPNVDBNBA-STQMWFEESA-N 0.000 description 1
- SECPVNVIQWIFME-RNJXMRFFSA-N CN[C@H]([C@H](C[C@H]1O[O]=C)N=O)C1=C Chemical compound CN[C@H]([C@H](C[C@H]1O[O]=C)N=O)C1=C SECPVNVIQWIFME-RNJXMRFFSA-N 0.000 description 1
- GVHBMTJMLMASQR-CIUDSAMLSA-N C[C@@H](OC1)O[C@@H](CC2)[C@@H]1C2=C Chemical compound C[C@@H](OC1)O[C@@H](CC2)[C@@H]1C2=C GVHBMTJMLMASQR-CIUDSAMLSA-N 0.000 description 1
- GVHBMTJMLMASQR-VGMNWLOBSA-N C[C@H](OC1)O[C@@H](CC2)[C@@H]1C2=C Chemical compound C[C@H](OC1)O[C@@H](CC2)[C@@H]1C2=C GVHBMTJMLMASQR-VGMNWLOBSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
- C07C41/26—Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/18—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C43/196—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
- C07C67/29—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by introduction of oxygen-containing functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
- C07C67/293—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/78—Benzoic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Abstract
Description
Claims (22)
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110196709.XA CN102336754B (zh) | 2010-07-15 | 2011-07-13 | 恩替卡韦的合成方法及其中间体化合物 |
CN201710152615.XA CN106928227B (zh) | 2010-07-15 | 2011-07-13 | 恩替卡韦的合成方法及其中间体化合物 |
PL18213624T PL3483161T3 (pl) | 2010-07-15 | 2011-07-15 | Związki pośrednie do otrzymywania entekawiru |
EP11806306.4A EP2594569B1 (en) | 2010-07-15 | 2011-07-15 | Entecavir synthesis method and intermediate compound thereof |
SI201131972T SI3483161T1 (sl) | 2010-07-15 | 2011-07-15 | Vmesne spojine za izdelavo entekavirja |
ES18213624T ES2874350T3 (es) | 2010-07-15 | 2011-07-15 | Intermedios utilizados para prepar entecavir |
PCT/CN2011/077195 WO2012006964A1 (zh) | 2010-07-15 | 2011-07-15 | 恩替卡韦的合成方法及其中间体化合物 |
KR1020137003701A KR101983033B1 (ko) | 2010-07-15 | 2011-07-15 | 엔테카비어의 합성 방법 및 그의 중간체 화합물 |
EP18213624.2A EP3483161B1 (en) | 2010-07-15 | 2011-07-15 | Intermediates used to make entecavir |
JP2013518944A JP6105467B2 (ja) | 2010-07-15 | 2011-07-15 | エンテカビルの合成方法及びその中間体化合物 |
CN201180003541.4A CN102630226B (zh) | 2010-07-15 | 2011-07-15 | 恩替卡韦的合成方法及其中间体化合物 |
ES11806306T ES2732042T3 (es) | 2010-07-15 | 2011-07-15 | Método de síntesis de entecavir y compuesto intermedio del mismo |
PL11806306T PL2594569T3 (pl) | 2010-07-15 | 2011-07-15 | Sposób syntezy entekawiru i jego związku pośredniego |
SI201131738T SI2594569T1 (sl) | 2010-07-15 | 2011-07-15 | Postopek sinteze entekavirja in njegove vmesne spojine |
US13/810,062 US9309249B2 (en) | 2010-07-15 | 2011-07-15 | Entecavir synthesis method and intermediate compound thereof |
KR1020197014172A KR102107429B1 (ko) | 2010-07-15 | 2011-07-15 | 엔테카비어의 합성 방법 및 그의 중간체 화합물 |
JP2016144062A JP6573848B2 (ja) | 2010-07-15 | 2016-07-22 | エンテカビルの合成方法及びその中間体化合物 |
JP2018073060A JP2018138559A (ja) | 2010-07-15 | 2018-04-05 | エンテカビルの合成方法及びその中間体化合物 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102301537 | 2010-07-15 | ||
CN201010230153.7 | 2010-07-15 | ||
CN201010230153 | 2010-07-15 | ||
CN201110196709.XA CN102336754B (zh) | 2010-07-15 | 2011-07-13 | 恩替卡韦的合成方法及其中间体化合物 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710152615.XA Division CN106928227B (zh) | 2010-07-15 | 2011-07-13 | 恩替卡韦的合成方法及其中间体化合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102336754A CN102336754A (zh) | 2012-02-01 |
CN102336754B true CN102336754B (zh) | 2017-04-12 |
Family
ID=45468943
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110196709.XA Active CN102336754B (zh) | 2010-07-15 | 2011-07-13 | 恩替卡韦的合成方法及其中间体化合物 |
CN201710152615.XA Active CN106928227B (zh) | 2010-07-15 | 2011-07-13 | 恩替卡韦的合成方法及其中间体化合物 |
CN201180003541.4A Active CN102630226B (zh) | 2010-07-15 | 2011-07-15 | 恩替卡韦的合成方法及其中间体化合物 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710152615.XA Active CN106928227B (zh) | 2010-07-15 | 2011-07-13 | 恩替卡韦的合成方法及其中间体化合物 |
CN201180003541.4A Active CN102630226B (zh) | 2010-07-15 | 2011-07-15 | 恩替卡韦的合成方法及其中间体化合物 |
Country Status (9)
Country | Link |
---|---|
US (1) | US9309249B2 (zh) |
EP (2) | EP3483161B1 (zh) |
JP (3) | JP6105467B2 (zh) |
KR (2) | KR102107429B1 (zh) |
CN (3) | CN102336754B (zh) |
ES (2) | ES2732042T3 (zh) |
PL (2) | PL3483161T3 (zh) |
SI (2) | SI2594569T1 (zh) |
WO (1) | WO2012006964A1 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112012001797B1 (pt) | 2009-07-28 | 2020-04-07 | Ono Pharmaceutical Co | composto bicíclico, composição farmacêutica e uso do referido composto para prevenir e tratar uma doença ocular |
CA2705953C (en) | 2010-05-31 | 2018-05-01 | Alphora Research Inc. | Carbanucleoside synthesis and intermediate compounds useful therein |
CN102336754B (zh) * | 2010-07-15 | 2017-04-12 | 浙江奥翔药业股份有限公司 | 恩替卡韦的合成方法及其中间体化合物 |
EP2597096A1 (en) * | 2011-11-24 | 2013-05-29 | Esteve Química, S.A. | Process for preparing entecavir and intermediates thereof |
WO2015051900A1 (en) * | 2013-10-08 | 2015-04-16 | Pharmathen S.A. | Process for the preparation of entecavir through novel intermediates |
CN105524064B (zh) * | 2014-09-30 | 2017-10-31 | 中国科学院广州生物医药与健康研究院 | 恩替卡韦的合成方法 |
CN105037363B (zh) * | 2015-07-13 | 2016-08-24 | 山东罗欣药业集团股份有限公司 | 一种恩替卡韦化合物的新合成方法 |
JP6954282B2 (ja) * | 2016-06-30 | 2021-10-27 | 小野薬品工業株式会社 | 二環式化合物の製造方法 |
CN108203435B (zh) * | 2016-12-16 | 2020-09-04 | 正大天晴药业集团股份有限公司 | 一种利用Boc保护基的恩替卡韦的制备方法 |
CN107163049B (zh) * | 2017-05-31 | 2019-06-18 | 湖北远大生命科学与技术有限责任公司 | 一种恩替卡韦的制备方法 |
EP3894395A2 (en) * | 2018-12-12 | 2021-10-20 | Janssen BioPharma, Inc. | Cyclopentyl nucleoside analogs as anti-virals |
CN112625041A (zh) * | 2020-12-25 | 2021-04-09 | 常州博海威医药科技股份有限公司 | 恩替卡韦的新制备方法以及中间体 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010074534A2 (en) * | 2008-12-26 | 2010-07-01 | Hanmi Pharm. Co., Ltd. | Novel intermediate and process for preparing entecavir using same |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6042348A (ja) * | 1983-08-19 | 1985-03-06 | Sagami Chem Res Center | (3−オキソ−1−アルケニル)−シス−ビシクロ〔3.3.0〕オクテン誘導体 |
DE3477776D1 (en) | 1983-08-19 | 1989-05-24 | Sagami Chem Res | Bicycloû3.3.0¨octane derivative and preparation thereof |
JPS60166644A (ja) * | 1984-02-10 | 1985-08-29 | Sagami Chem Res Center | シス−ビシクロ〔3.3.0〕オクチリデン誘導体の製造方法 |
JPS6468367A (en) * | 1987-09-08 | 1989-03-14 | Ono Pharmaceutical Co | Novel bicyclic ethers or lactones |
DE4024347A1 (de) * | 1990-07-27 | 1992-01-30 | Schering Ag | Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung |
AU4090697A (en) * | 1996-09-03 | 1998-03-26 | Bristol-Myers Squibb Company | Improved process for preparing the antiviral agent {1s-(1alpha, 3alpha, 4beta)}-2-amino-1,9-dihydro-9-{4-hydroxy-3-(hydroxymethyl)-2 -methylenecyclopentyl}-6h-purin-6-one |
PL397715A1 (pl) | 2002-12-11 | 2012-03-26 | Bristol-Myers Squibb Company | Pochodna cyklopentadienowa i sposób jej wytwarzania |
US7863983B2 (en) | 2003-05-20 | 2011-01-04 | Epic Communications, Inc. | Smart linearized power amplifier and related systems and methods |
CN100379736C (zh) | 2005-05-13 | 2008-04-09 | 上海仲夏化学有限公司 | 恩替卡韦的制备方法 |
CN101130542B (zh) * | 2006-08-24 | 2010-08-04 | 江苏正大天晴药业股份有限公司 | 抗病毒核苷类似物的合成方法 |
CN101148450A (zh) * | 2007-11-02 | 2008-03-26 | 严红芳 | 一种核苷化合物的制备方法 |
KR101301200B1 (ko) | 2009-10-12 | 2013-09-06 | 한미사이언스 주식회사 | 엔테카비르의 신규한 제조방법 및 이에 사용되는 중간체 |
US8481728B2 (en) * | 2010-02-16 | 2013-07-09 | Scinopharm Taiwan, Ltd. | Process for preparing entecavir and its intermediates |
CA2705953C (en) | 2010-05-31 | 2018-05-01 | Alphora Research Inc. | Carbanucleoside synthesis and intermediate compounds useful therein |
CN102336754B (zh) * | 2010-07-15 | 2017-04-12 | 浙江奥翔药业股份有限公司 | 恩替卡韦的合成方法及其中间体化合物 |
-
2011
- 2011-07-13 CN CN201110196709.XA patent/CN102336754B/zh active Active
- 2011-07-13 CN CN201710152615.XA patent/CN106928227B/zh active Active
- 2011-07-15 EP EP18213624.2A patent/EP3483161B1/en active Active
- 2011-07-15 KR KR1020197014172A patent/KR102107429B1/ko active IP Right Grant
- 2011-07-15 SI SI201131738T patent/SI2594569T1/sl unknown
- 2011-07-15 ES ES11806306T patent/ES2732042T3/es active Active
- 2011-07-15 PL PL18213624T patent/PL3483161T3/pl unknown
- 2011-07-15 US US13/810,062 patent/US9309249B2/en active Active
- 2011-07-15 PL PL11806306T patent/PL2594569T3/pl unknown
- 2011-07-15 JP JP2013518944A patent/JP6105467B2/ja active Active
- 2011-07-15 CN CN201180003541.4A patent/CN102630226B/zh active Active
- 2011-07-15 EP EP11806306.4A patent/EP2594569B1/en active Active
- 2011-07-15 SI SI201131972T patent/SI3483161T1/sl unknown
- 2011-07-15 KR KR1020137003701A patent/KR101983033B1/ko active IP Right Grant
- 2011-07-15 ES ES18213624T patent/ES2874350T3/es active Active
- 2011-07-15 WO PCT/CN2011/077195 patent/WO2012006964A1/zh active Application Filing
-
2016
- 2016-07-22 JP JP2016144062A patent/JP6573848B2/ja active Active
-
2018
- 2018-04-05 JP JP2018073060A patent/JP2018138559A/ja active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010074534A2 (en) * | 2008-12-26 | 2010-07-01 | Hanmi Pharm. Co., Ltd. | Novel intermediate and process for preparing entecavir using same |
Also Published As
Publication number | Publication date |
---|---|
JP2018138559A (ja) | 2018-09-06 |
SI3483161T1 (sl) | 2021-06-30 |
KR102107429B1 (ko) | 2020-05-07 |
CN106928227B (zh) | 2020-06-30 |
PL2594569T3 (pl) | 2019-09-30 |
ES2732042T3 (es) | 2019-11-20 |
JP6105467B2 (ja) | 2017-03-29 |
EP3483161A1 (en) | 2019-05-15 |
CN102336754A (zh) | 2012-02-01 |
SI2594569T1 (sl) | 2019-10-30 |
CN106928227A (zh) | 2017-07-07 |
JP2016196499A (ja) | 2016-11-24 |
WO2012006964A1 (zh) | 2012-01-19 |
US20130217879A1 (en) | 2013-08-22 |
EP2594569A1 (en) | 2013-05-22 |
EP2594569B1 (en) | 2019-03-20 |
CN102630226A (zh) | 2012-08-08 |
US9309249B2 (en) | 2016-04-12 |
KR101983033B1 (ko) | 2019-05-28 |
ES2874350T3 (es) | 2021-11-04 |
KR20190059987A (ko) | 2019-05-31 |
JP2013532174A (ja) | 2013-08-15 |
KR20130089250A (ko) | 2013-08-09 |
EP2594569A4 (en) | 2014-01-08 |
JP6573848B2 (ja) | 2019-09-11 |
CN102630226B (zh) | 2014-01-22 |
PL3483161T3 (pl) | 2021-09-20 |
EP3483161B1 (en) | 2021-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102336754B (zh) | 恩替卡韦的合成方法及其中间体化合物 | |
US10858324B2 (en) | Processes for the preparation of pyrimidinylcyclopentane compounds | |
CN101531660A (zh) | 一种恩替卡韦一水合物的工业化生产工艺 | |
TWI668220B (zh) | 恩替卡韋的合成方法及其中間體化合物 | |
CN103387587B (zh) | 恩替卡韦中间体及其制备方法 | |
JP2000264878A (ja) | 1−[(シクロペント−3−エン−1−イル)メチル]−5−エチル−6−(3,5−ジメチルベンゾイル)−2,4−ピリミジンジオンの製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: ZHEJIANG AOXIANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: TAIZHOU AUSUN PHARMATECH CO., LTD. Effective date: 20130123 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 318000 TAIZHOU, ZHEJIANG PROVINCE TO: 317016 TAIZHOU, ZHEJIANG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20130123 Address after: 317016 Zhejiang chemical raw materials base in the East China Sea Park Road, No. fourth, No. 5 Applicant after: Zhejiang Ausun Pharmaceutical Co., Ltd. Address before: Jiaojiang District of Taizhou City, Zhejiang province 318000 road outside No. 282 Applicant before: Ausun Pharmatech. Co., Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 317016 Zhejiang chemical raw materials base in the East China Sea Park Road, No. fourth, No. 5 Applicant after: Zhejiang Ao Xiang medicine company limited-liability company Address before: 317016 Zhejiang chemical raw materials base in the East China Sea Park Road, No. fourth, No. 5 Applicant before: Zhejiang Ausun Pharmaceutical Co., Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: ZHEJIANG AOXIANG PHARMACEUTICAL CO., LTD. TO: ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |